Obsidian Financial Communications Inc.
Thursday, January 26, 2012
Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish...
http://ow.ly/1gXjPZ
Newer Post
Older Post
Home